These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 2963053)

  • 21. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Marks IM; De Albuquerque A; Cottraux J; Gentil V; Greist J; Hand I; Liberman RL; Relvas JS; Tobeña A; Tyrer P
    Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772
    [No Abstract]   [Full Text] [Related]  

  • 22. Alprazolam and amitriptyline in the treatment of moderate depression.
    Lapierre YD; Browne M; Oyewumi K; Sarantidis D
    Int Clin Psychopharmacol; 1994; 9(1):41-5. PubMed ID: 8195582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    Maier W; Albus M; Buller R; Nutzinger D; Shera D; Bech P
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):103-8. PubMed ID: 2149648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect size as a measure of symptom-specific drug change in clinical trials.
    Leon AC; Shear MK; Portera L; Klerman GL
    Psychopharmacol Bull; 1993; 29(2):163-7. PubMed ID: 8290660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
    Cox BJ; Swinson RP; Endler NS
    Can J Psychiatry; 1991 Mar; 36(2):130-8. PubMed ID: 2044033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panic Disorder Severity Scale: reliability and validity of the Turkish version.
    Monkul ES; Tural U; Onur E; Fidaner H; Alkin T; Shear MK
    Depress Anxiety; 2004; 20(1):8-16. PubMed ID: 15368591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential treatment of panic disorder with alprazolam and imipramine.
    Goldstein S
    Am J Psychiatry; 1986 Dec; 143(12):1634. PubMed ID: 3789226
    [No Abstract]   [Full Text] [Related]  

  • 31. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the Cross-National Collaborative Panic Study.
    Klerman GL
    Arch Gen Psychiatry; 1988 May; 45(5):407-12. PubMed ID: 3282477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.
    Kahn RJ; McNair DM; Lipman RS; Covi L; Rickels K; Downing R; Fisher S; Frankenthaler LM
    Arch Gen Psychiatry; 1986 Jan; 43(1):79-85. PubMed ID: 3510602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
    Kravitz HM; Fogg L; Fawcett J; Edwards J
    Psychiatry Res; 1990 May; 32(2):141-9. PubMed ID: 2195576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A re-examination of the clinical effects of imipramine and amitriptyline in depressive illness.
    Beaini AY; Hindmarch I; Snaith RP
    J Affect Disord; 1980 Jun; 2(2):89-94. PubMed ID: 6448887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical interview for depression. Development, reliability and validity.
    Paykel ES
    J Affect Disord; 1985 Jul; 9(1):85-96. PubMed ID: 3160752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forms of atypical depression and their response to antidepressant drugs.
    Davidson J; Pelton S
    Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.